Suppr超能文献

皮质类固醇和局部麻醉剂在大关节和滑囊注射中的使用趋势:一项对运动医学医师的调查结果。

Corticosteroid and Local Anesthetic Use Trends for Large Joint and Bursa Injections: Results of a Survey of Sports Medicine Physicians.

机构信息

Division of Physical Medicine & Rehabilitation, University of Utah, Salt Lake City, UT.

Department of Physical Medicine & Rehabilitation, University of Texas Health Science Center, San Antonio, TX.

出版信息

PM R. 2021 Sep;13(9):962-968. doi: 10.1002/pmrj.12499. Epub 2020 Nov 23.

Abstract

BACKGROUND

Physician decision-making surrounding choices for large joint and bursa injections is poorly defined, yet influences patient safety and treatment effectiveness.

OBJECTIVE

To identify practice patterns and rationale related to injectate choices for large joint and bursal injections performed by physician members of the American Medical Society for Sports Medicine (AMSSM).

DESIGN

An electronic survey was sent to 3400 members of the AMSSM. Demographic variables were collected: primary specialty (residency), training location, practice location, years of clinical experience, current practice type, and rationale for choosing an injectate.

PARTICIPANTS

A total of 674 physicians responded (minimum response rate of 20%).

INTERVENTION

Not applicable.

MAIN OUTCOME MEASURES

Outcomes of interest included corticosteroid type and dose, local anesthetic type, and total injectate volume for each large joint or bursa (hip, knee, and shoulder).

RESULTS

Most respondents used triamcinolone (50% to 56% of physicians, depending on injection location) or methylprednisolone (25% to 29% of physicians), 21 to 40 mg (53% to 60% of physicians), diluted with lidocaine (79% to 87%) for all large joint or bursa injections. It was noted that 36.2% (244/674) of respondents reported using >40 mg for at least one injection type. Most (90.5%, 610/674) reported using an anesthetic other than ropivacaine for at least one type of joint or bursa injection. Physicians who reported lidocaine use were less likely to report that their injectate choice was based on the literature that they reviewed (odds ratio [OR] 0.41 [0.27-0.62], P < .001). Respondents predominantly used 5 to 7 mL of total injectate for all large joints or bursae (45% to 54% of respondents), except for the pes anserine bursa, where 3-4 mL was more common (51% of physicians).

CONCLUSIONS

It appears that triamcinolone and methylprednisolone are the most commonly used corticosteroids for sports medicine physicians; most physicians use 21 to 40 mg of corticosteroid for all injections, and lidocaine is the most-often used local anesthetic; very few use ropivacaine. Over one-third of respondents used high-dose (>40 mg triamcinolone or methylprednisolone) for at least one joint or bursa.

摘要

背景

美国运动医学学会(AMSSM)的医师在选择大关节和滑囊注射时,其决策方法并不明确,但会影响患者的安全和治疗效果。

目的

确定 AMSSM 医师进行大关节和滑囊注射时选择注射剂的实践模式和原理。

设计

向 AMSSM 的 3400 名成员发送了电子调查。收集了人口统计学变量:主要专业(住院医师)、培训地点、实践地点、临床经验年限、当前实践类型以及选择注射剂的原理。

参与者

共有 674 名医生做出了回应(最低回应率为 20%)。

干预措施

不适用。

主要观察指标

感兴趣的结果包括每个大关节或滑囊(髋、膝和肩)的皮质类固醇类型和剂量、局部麻醉剂类型和总注射量。

结果

大多数受访者使用曲安奈德(50%至 56%的医生,取决于注射部位)或甲泼尼龙(25%至 29%的医生),21 至 40mg(53%至 60%的医生),用利多卡因稀释(79%至 87%)用于所有大关节或滑囊注射。值得注意的是,36.2%(244/674)的受访者报告说至少有一种注射类型使用了>40mg。大多数(90.5%,610/674)报告至少有一种关节或滑囊注射使用了除罗哌卡因以外的麻醉剂。报告使用利多卡因的医生不太可能表示他们的注射剂选择是基于他们审查的文献(优势比[OR]0.41[0.27-0.62],P<.001)。受访者主要使用 5 至 7ml 的总注射量用于所有大关节或滑囊(45%至 54%的受访者),除了鹅足滑囊炎,其中 3 至 4ml 更为常见(51%的医生)。

结论

曲安奈德和甲泼尼龙似乎是运动医学医师最常使用的皮质类固醇;大多数医生对所有注射使用 21 至 40mg 的皮质类固醇,利多卡因是最常使用的局部麻醉剂;很少使用罗哌卡因。超过三分之一的受访者至少有一种关节或滑囊使用了高剂量(>40mg 曲安奈德或甲泼尼龙)。

相似文献

本文引用的文献

2
Cytotoxicity of drugs injected into joints in orthopaedics.骨科关节内注射药物的细胞毒性
Bone Joint Res. 2019 Mar 2;8(2):41-48. doi: 10.1302/2046-3758.82.BJR-2018-0099.R1. eCollection 2019 Feb.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验